Mark A. Kronenfeld - 14 Jun 2023 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role: Director
Signature: /s/ Kristen Williams, Attorney-in-Fact
Issuer symbol: PCRX
Transactions as of: 14 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 16 Jun 2023, 17:34:16 UTC
Previous filing: 12 Jun 2023
Next filing: 13 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCRX	Common Stock	Award	$0	+1,775	+9.9%	$0.000000	19,672	14 Jun 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCRX	Stock Option (Right to Buy)	Award	$0	+12,925		$0.000000	12,925	14 Jun 2023	Common Stock	12,925	$38.74	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units that vest on June 3, 2024, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.